Ensysce Biosciences Cash from Financing (TTM) Trends

Ensysce Biosciences Inc (ENSC)

0.5901 +0.04 (+7.94%) USD | NASDAQ | Apr 26, 16:00

0.5901 0.00 (0.00%) After-Hours: 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
December 31, 2023	8.756M
September 30, 2023	9.235M
June 30, 2023	16.82M
March 31, 2023	11.03M
December 31, 2022	8.766M

Date	Value
September 30, 2022	16.01M
June 30, 2022	11.19M
March 31, 2022	19.31M
December 31, 2021	20.31M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

8.756M

Minimum

Dec 2023

20.31M

Maximum

Dec 2021

13.49M

Average

11.19M

Median

Jun 2022

Cash from Financing (TTM) Benchmarks